Stay updated on ADG126 + Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision bumped from v3.6.4 to v3.6.5 in the page history, signaling an internal software update to the record history interface.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe Record History now shows the platform revision updated to v3.6.4, replacing v3.6.3. This is a system update to the ClinicalTrials.gov interface and does not change the study data or its presentation beyond the version label.SummaryDifference0.1%

- Check47 days agoChange DetectedThe study record history now shows a new Revision: v3.6.3 entry and removes the previous Revision: v3.6.2 entry, reflecting an updated release in the history log.SummaryDifference0.1%

- Check54 days agoChange DetectedThe study record history now shows a new revision entry for v3.6.2. The previous v3.6.0 entry has been removed, updating the version history.SummaryDifference0.1%

- Check68 days agoChange DetectedNew quick links 'Check who can join' and 'Find Contact Information' appear on the record history page, facilitating eligibility checks and contact access. The revision note now shows Revision: v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.5%

- Check75 days agoChange DetectedThe version history now shows a new release entry for v3.5.5, replacing the previous v3.5.4. This reflects a backend/UI update without changes to the study details.SummaryDifference0.1%

Stay in the know with updates to ADG126 + Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.